IPOPLUS

104

-25.7 -19.81%

11 May 2026

NSE Listed · Pharmaceuticals

Curis Lifesciences Ltd. (CURIS)

Volume: 3,000Avg Vol 1W: 7,000Avg Vol 1M: 8,81852W Range:104104.4
₹104 19.81%
Market Cap₹91 Cr
Current Price₹104
Previous Close₹129.7
High / Low (52w)₹104.4 / ₹104
Volume3,000
Avg Vol (1W)7,000
Avg Vol (1M)8,818
Stock P/E
Book Value₹32.19
Dividend Yield0%
ROE0%
ROA0%
Revenue (TTM)
Revenue Growth
Profit Margin13.16%
Total Debt
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹2.26
P/B3.23
Debt / Equity2.45
50 DMA₹104.51
200 DMA
Day change-19.81%
Price Chart
127.05 15.50% · 1Y
140891.2L
2026-02-09
2026-05-11

20-day avg volume: 7K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 38% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricJun 2025Jun 2024
Revenue₹20 Cr₹9 Cr
EBITDA₹4 Cr₹3 Cr
Net Profit₹3 Cr₹1 Cr
EPS4.8424
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹50 Cr₹36 Cr₹36 Cr₹24 Cr
EBITDA₹9 Cr₹8 Cr₹3 Cr₹3 Cr
Net Profit₹6 Cr₹5 Cr₹1 Cr₹0 Cr
EPS10.29107.1324.529.85
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022
Total Assets₹43 Cr₹34 Cr₹30 Cr₹27 Cr
Total Liabilities₹26 Cr₹28 Cr₹29 Cr₹28 Cr
Equity₹16 Cr₹6 Cr₹0 Cr₹-1 Cr
Total Debt₹7 Cr₹9 Cr₹10 Cr₹12 Cr
Cash Flow
MetricMar 2024Mar 2023Mar 2022
Operating₹2 Cr₹3 Cr₹5 Cr
Investing₹0 Cr₹-1 Cr₹0 Cr
Financing₹0 Cr₹-3 Cr₹-5 Cr
Free Cash Flow₹2 Cr₹3 Cr₹5 Cr
Shareholding
Promoter 68.03% Institutions 6.99% Public 24.98%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search